Verona Pharma

December 18, 2020

First-quarter catalysts for the smaller players

Important data releases are on the cards for Rhythm, Wave and Supernus, among others.

January 13, 2020

Clinical win gives Verona a kiss of life

For Verona’s long-suffering shareholders today brought an unexpected clinical success with ensifentrine.

January 14, 2019

Verona’s failure highlights a broader problem

December 14, 2018

Upcoming events – Verona waits to exhale and a new test for Alexion

Verona Pharma needs another COPD win, while Alexion seeks a new use for its Soliris successor.

March 26, 2018

Verona’s transformation clears its first hurdle

March 02, 2018

Hope, or a new emotion for Verona investors

September 07, 2017

Circassia and Verona cough up some good news

July 26, 2017

Interview – Verona investors still holding their breath

July 05, 2017

Interview – Arix ventures to build better returns

April 19, 2017

Galapagos shows a European HQ is no barrier to riches

September 30, 2010

EP Vantage Interview - Verona playing hardball for inhaler deal